DPT Meeting: Panel 1 – Protocol Objectives & Eligibility PANEL Discussion 1: Protocol Objectives and Eligibility Moderators: Abby Bronson, Scott Berry Panelists: Joanne Donovan, MD, PhD, Catabasis Pharmaceuticals Michael Panzara, MD, MPH, Wave Life Sciences Hank Mayer, MD, Children’s Hospital of Philadelphia Paula Clemens, MD, University of Pittsburgh Gretchen Egner, Parent/Advocate 7 years ago 2019 Duchenne Platform Trial Stakeholder Meeting,Conferences & Meetings You may also like Exploring the Landscape of Gene Therapy – 2025 PPMD Annual Conference 1 year ago 2025 PPMD Annual Conference,Conferences & Meetings Trials & Treatments: Making Decisions that are Right for You – 2025 PPMD Annual Conference 1 year ago 2025 PPMD Annual Conference,Conferences & Meetings Building Friendships & Self Advocacy Skills – 2025 PPMD Annual Conference 1 year ago 2025 PPMD Annual Conference,Conferences & Meetings Keynote Address: Meeting the Challenge of Rare Disease – 2025 PPMD Annual Conference 1 year ago 2025 PPMD Annual Conference,Conferences & Meetings Approved Therapies & Sequential Therapy – PPMD 2025 Annual Conference 1 year ago 2025 PPMD Annual Conference,Conferences & Meetings How Do We Get to the Next Step in Research? The DCRN Explained – 2025 PPMD Annual Conference 1 year ago 2025 PPMD Annual Conference,Conferences & Meetings Dystrophin: The Missing Muscle Protein – 2025 PPMD Annual Conference 1 year ago 2025 PPMD Annual Conference,Conferences & Meetings Exercise: How Much is Too Much? – 2025 PPMD Annual Conference 1 year ago 2025 PPMD Annual Conference,Conferences & Meetings «12345…29»Page 3 of 29